WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese company seeks to enhance its margins while continuing to navigate ...

WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 for the Chinese biotech and drug companies after the US Biosecure legislation that threatened to cut them out from ...

Wuxi Biologics (Cayman) Inc. announced a significant asset transaction involving its Vaccines Ireland Facility, selling it to MSD International for approximately US$500 million. The transaction ...

WUXI Biologics Cayman will sell a vaccine facility in Ireland to Merck for about US$500 million as the Chinese company seeks to enhance its margins while continuing to navigate geopolitical tensions.

WuXi Biologics (Cayman) Inc. has announced a change in its principal place of business in Hong Kong, effective January 10, 2025, to Room 1910, 19/F, Lee Garden One, Causeway Bay. This relocation ...

WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

1 Day WXIBF 2.68% DJIA 0.92% S&P 500 0.53% Health Care/Life Sciences 0.09% ...

Leverage fair value analysis to evaluate the market value of stocks enabling more informed investment decisions.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.